The Bcc qPCR NAD assay presented is an internally controlled duplex assay (incorporating an IAC), targeting a region of the smpB gene for the specific rapid quantitative detection of all Bcc species. This Bcc qPCR NAD assay was validated with equivalence to ISO/TS 12869:2019 with high specificity (100% when tested on an extensive panel of target and non-target microorganisms with no cross-reactivity observed) and high analytical sensitivity (relatively low LOD and LOQ at 3 GE/reaction with ≥90% probability and 20 GE/reaction, respectively). The high performance of the calibration function of the Bcc qPCR NAD assay in terms of accuracy, qPCR efficiency and broad dynamic calibration range (20 GE-107GE/reaction) will allow for the absolute quantification of the starting Bcc DNA concentration in contaminated samples. The incorporation of the IAC into the Bcc qPCR NAD assay ensures the robustness and fidelity of the results generated. The development and validation of this Bcc qPCR NAD assay has been published in: Duong HT, Fullbrook S, Reddington K, Minogue E, Barry T. Design, Development and Validation of a Culture-Independent Nucleic Acid Diagnostics Method for the Rapid Detection and Quantification of the Burkholderia cepacia Complex in Water with an Equivalence to ISO/TS 12869:2019. PDA Journal of Pharmaceutical Science and Technology. 2023. doi:10.5731/pdajpst.2021.012728